From: An integrative approach to identifying cancer chemoresistance-associated pathways
User interested gene symbols | ⟡ CEBPD (CCAAT/enhancer binding protein (C/EBP), delta) ⟡ SOD1(superoxide dismutase 1, soluble) ⟡ XRCC4 (X-ray repair complementing defective repair in Chinese hamster cells 4) ⟡ PTGS2 (prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase), (COX2)) ⟡ RBMS3 (RNA binding motif, single stranded interacting protein) ⟡ STK39 (serine threonine kinase 39 (STE20/SPS1 homolog, yeast)) ⟡ CUTL1 (cut-like homeobox 1) ⟡ CREG1 (cellular repressor of E1A-stimulated genes 1) ⟡ APBB2 (amyloid beta (A4) precursor protein-binding, family B, member 2) ⟡ ADAMTS1(ADAM metallopeptidase with thrombospondin type 1 motif, 1) ⟡ JAZF1(JAZF zinc finger 1) ⟡ JMJD2C (Jumonji domain 2) ⟡ MSI2 (musashi homolog 2 (Drosophila)) ⟡ RABGAP1L (RAB GTPase activating protein 1-like) ⟡ NAV2 (neuron navigator 2) ⟡ ZMIZ1 (zinc finger, MIZ-type containing 1) ⟡ ZNF291 (SCAPER, S-phase cyclin A-associated protein in the ER) ⟡ ZRANB3 (zinc finger, RAN-binding domain containing 3) ⟡ CENTG2 (AGAP1, Homo sapiens ArfGAP with GTPase domain, ankyrin repeat and PH) ⟡ ATXN1 (ataxin 1-like) ⟡ THSD4 (thrombospondin, type I, domain containing 4) ⟡ CYP27C1 (cytochrome P450, family 27, subfamily C, polypeptide 1) |
Resistance genes | ⟡ IL1A (interleukin 1, alpha) ⟡ IL1B (interleukin 1, beta) ⟡ NFKB1 (nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) ⟡ NFKB2 (nuclear factor of kappa light polypeptide gene enhancer in B-cells 2) ⟡ CDK4 (cyclin-dependent kinase 4) ⟡ MCM2 (minichromosome maintenance complex component 2) ⟡ MCM4 (minichromosome maintenance complex component 4) ⟡ CDC45L (CDC45 cell division cycle 45-like (S. cerevisiae)) |
DNA damage genes | ⟡ MYC (v-myc myelocytomatosis viral oncogene homolog (avian)) ⟡ TP53 (tumor protein p53) ⟡ PCNA (proliferating cell nuclear antigen) ⟡ TP73 (tumor protein p73) ⟡ ATF4 (activating transcription factor 4 (tax-responsive enhancer element B67)) |